|
|
Volumn 20, Issue 7, 2002, Pages 659-663
|
|
Therapeutic cancer vaccines on trial
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
DRUG THERAPY;
PATIENT TREATMENT;
TUMORS;
VACCINES;
OBSTACLES;
BIOTECHNOLOGY;
ALLOVECTIN 7;
AVICINE;
BCG VACCINE;
BEC2;
CANCER VACCINE;
CEAVAC;
DCVAX;
GASTRIMMUNE;
MVAX;
ONCOPHAGE;
ONCOVAX;
PROVENGE;
THERACYS;
BLADDER CANCER;
CANCER;
CLINICAL TRIAL;
COLORECTAL CANCER;
COST OF ILLNESS;
DENDRITIC CELL;
DRUG APPROVAL;
DRUG MARKETING;
DRUG MECHANISM;
FOOD AND DRUG ADMINISTRATION;
HUMAN;
KIDNEY CARCINOMA;
LUNG SMALL CELL CANCER;
MELANOMA;
NONHODGKIN LYMPHOMA;
PANCREAS CANCER;
PRIORITY JOURNAL;
PROSTATE CANCER;
REVIEW;
TREATMENT FAILURE;
ARTICLE;
DRUG INDUSTRY;
IMMUNOLOGY;
NEOPLASM;
RETROSPECTIVE STUDY;
UNITED STATES;
VACCINATION;
CANCER VACCINES;
CLINICAL TRIALS;
DRUG APPROVAL;
DRUG INDUSTRY;
HUMAN;
NEOPLASMS;
RETROSPECTIVE STUDIES;
SUPPORT, NON-U.S. GOV'T;
UNITED STATES;
VACCINATION;
HUMANS;
|
|
EID: 0035989621
PISSN: 10870156
EISSN: None
Source Type: Journal
DOI: 10.1038/nbt0702-659 Document Type: Review |
|
Times cited : (11)
|
|
References (11)
|
